Since the historical use of gonadotrophin and estradiol levels to define the different anovulatory disorders has shown some limitations, the use of other markers such as anti-müllerian hormone (AMH) has been proposed. This review addresses the role of AMH in the differential diagnosis of anovulatory disorders, especially focusing on its value in the prognostic characterization of their severity. Current limitations and future clinical applications are discussed.
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS / Capuzzo, M.; La Marca, A.. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 11:(2021), pp. N/A-N/A. [10.3389/fendo.2020.616766]
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS
Capuzzo M.;La Marca A.
2021
Abstract
Since the historical use of gonadotrophin and estradiol levels to define the different anovulatory disorders has shown some limitations, the use of other markers such as anti-müllerian hormone (AMH) has been proposed. This review addresses the role of AMH in the differential diagnosis of anovulatory disorders, especially focusing on its value in the prognostic characterization of their severity. Current limitations and future clinical applications are discussed.
| File | Dimensione | Formato | |
|---|---|---|---|
|
fendo-11-616766.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
257.21 kB
Formato
Adobe PDF
|
257.21 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
